|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Activating mutation in the tyrosinc kinase JAK2 in polycythemia vent , essential thrombocythemia and myeloid metaplasia with myelofibrosis显示文摘 | Levine RL Wadleigh M | 2005 | Cancer Cell2005，7，4： | 1 |
| 2 | Hepatic veno-occlusive disease:pathogenesis,diagnosis and treatment显示文摘 | Wadleigh M Ho V Momtaz P | 2003 | Curr Opin Hematol2003，10，6： | 1 |
| 3 | Classification and diagnosis of myelopmliferative neoplasms according to the 2008 World Health Organization criteria显示文摘 | Wadleigh M Tefferi A | 2010 | Int J Hematol2010，91，2： | 1 |
| 4 | Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis显示文摘 | Levine RL Wadleigh M Cools J | 2005 | Cancer Cell2005，7，4： | 1 |
| 5 | X inactivation based clonality analysis and quantitative JAK2 V617F assessment reveal a strong association between clonality and JAK2 V617F in PV but not ET/MMM, and identifies a subset of JAK2 V617F negative ET and MMM patient s with clonal hematopoiesis显示文摘 | Levine RL Belisl EC Wadleigh M | 2006 | Blood2006，107，10： | 1 |
| 6 | Activating Mutation in the Tyrosine Kinase JAK2 in Polycythemia Vera, Essential Thrombocythemia,and Myeloid Metaplasia with MycloSibrosis 显示文摘 | Levine R L Wadleigh M Cools J | 2005 | Cancer Cell2005，7，4： | 1 |
| 7 | Activating mutation in the tyrosine kinase JAN2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis显示文摘 | LEVINE R L WADLEIGH M COOLS J | 2005 | Cancer Cell2005，7，： | 1 |
| 8 | Activating mutation in the tyrosine kinase JAK2 in polycythemia vera,essential thrombocythemia,and myeloid metaplasia with myelofibrosis显示文摘 | Levine RL Wadleigh M Cools J | 2005 | Cancer Cell2005，7，4： | 1 |
| 9 | Classification and diagnosis of myeloproliferative neoplasms according to the 2008 World Health Organization criteria显示文摘 | Wadleigh M Tefferi A | 2010 | Int J Hematol2010，91，2： | 1 |
| 10 | Classification and diagnosis of myel- opmliferative neoplasms according to the 2008 World Health Organization criteria显示文摘 | Wadleigh M Tefferi A | 2010 | Int J Hematol2010，91，2： | 1 |
| 11 | Activating mutation in the tyrosine kinase JAK2 in polycythemia vera,essential thrombocythemia,and myeloid metaplasia with myelofibrosis显示文摘 | Levine RL Wadleigh M Cools J | | 0，，4： | 1 |
| 12 | Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis 显示文摘 | Levine R L Wadleigh M Cools J | 2005 | Cancer Cell2005，7，4： | 1 |
| 13 | Acti-vating mutation in the tyrosine kinase JAK2in poly-cythemia vera,essential thrombocythemia,and mye-loid metaplasia with myelofibrosis显示文摘 | LEVINE R L WADLEIGH M COOLS J | 2005 | Cancer Cell2005，7，： | 1 |
| 14 | Activiting mutation in thetyrosine kinase JAK2 polycythaemia vera, essential thrombythemia, and myeloid metaplasia with myelofibrosis 显示文摘 | Levine RL Wadleigh M Cools J | 2005 | Cancer Cell2005，7，4： | 1 |
| 15 | Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis 显示文摘 | Levine RL Wadleigh M Cools J | 2005 | Cancer Cell2005，7，4： | 1 |
| 16 | Activating mutation in the tyrosine kinase JAK2 in polycythemia vera,essential thrombocythemia,and myeloid metaplasia with myelofibrosis显示文摘 | Levine RL Wadleigh M Cools J | | 0，，04： | 1 |
| 17 | Classification and diagnosis of myeloproliferative neoplasms according to the 2008 World Health Organization criteria显示文摘 | Wadleigh M Tefferi A | | 0，，02： | 1 |
| 18 | KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloprolif- erative disease associated with a t(5 ;14 ) (q33 ;q32 ) 显示文摘 | Levine RL Wadleigh M Sternberg DW | 2005 | Leu- kemia2005，19，1： | 1 |
| 19 | Activatingmutation in the tyrosinekinase JAK2in polysythemia vera,es-sential thrombocythemia,and myeloid metaplasia with myelo-fibrosis显示文摘 | LEVINE R L WADLEIGH M COOLS J | 2005 | Cancer Cell2005，7，： | 1 |
| 20 | Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thromboythemia, and myeloid metaplasia with myelofibrosis显示文摘 | l_evine RL Wadleigh M Cools J | 2005 | Cancer Cell2005，7，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员